SEC Form 4 · accession 0001093557-15-000378
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew K Balo
Officer — EVP, Clinical, Regulatory
Period of report
Nov 23, 2015
Accepted (ET)
Nov 24, 2015 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 23, 2015 | M | 5,200 | $3.19 | A | 118,357 | D | |
| Common StockF1 | Nov 23, 2015 | S | 5,200 | $86.50 | D | 113,157 | D | |
| Common Stock | Nov 24, 2015 | M | 4,800 | $3.19 | A | 117,957 | D | |
| Common StockF1 | Nov 24, 2015 | S | 4,800 | $86.3612 | D | 113,157 | D | |
| Common StockF2,F1 | Nov 24, 2015 | G | 5,477 | $0.00 | D | 107,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $3.19 | Nov 23, 2015 | M | 5,200 | D | Dec 11, 2009 | Dec 11, 2018 | Common Stock | 5,200 | 112,299 | D |
| Non-Qualified Stock Option (right to buy) | $3.19 | Nov 24, 2015 | M | 4,800 | D | Dec 11, 2009 | Dec 11, 2018 | Common Stock | 4,800 | 107,499 | D |
Explanation of responses
- F1Included in this number are 80,834 unvested restricted stock units, 47,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 25,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 8,334 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
- F2This transaction represents a gift made by the reporting person. This is not a market transaction, thus no price has been reported.